News and Analysis | Published:

Preclinical antibiotic pipeline gets a pick-me-up

Nature Reviews Drug Discovery volume 16, pages 741742 (2017) | Download Citation

CARB-X, a public–private partnership aimed at bolstering the antibiotic pipeline, funded a diverse set of 17 early-stage drug development projects in its first year.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nrd.2017.213

Authors

  1. Search for Asher Mullard in:

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing